Global Extracorporeal Membrane Oxygenation (ECMO) Market Report 2020: Emergence of New Participants with Integrated and Advanced Circuit Solutions Set to Drive Inorganic Growth Strategy
Extracorporeal membrane oxygenation (ECMO) therapy has been in the limelight during the recent COVID-19 pandemic. This was due to its live-saving importance by improving the oxygenation, while providing pulmonary tissues adequate healing time, in patients suffering from acute respiratory distress syndrome (ARDS) caused by the viral infection. However, ECMO therapy had started gaining wider acceptance among critical care physicians post the 2009 influenza A (H1N1) pandemic. The driver was the consecutive generation of clinical trial evidence and multiple research studies proving its benefits...
Source: prnewswire.com